2020年全国医院感染监控网丙型肝炎病毒感染监测报告  

Hepatitis C virus infection:surveillance report from China Healthcare-associated Infection Surveillance System in 2020

作　　者：文细毛[1,2] 任南[1] 李福琴[3] 战榕[4] 方旭[5] 孟庆兰[6] 杨怀[7] 李卫光 刘丁 郭凤玲 鲜于舒铭[11] 赖晓全 逄崇杰[13] 黄勋[1] 吴安华[1] WEN Xi-mao;REN Nan;LI Fu-qin;ZHAN Rong;FANG Xu;MENG Qing-lan;YANG Huai;LI Wei-guang;LIU Ding;GUO Feng-ling;XIANYU Shu-ming;LAI Xiao-quan;PANG Chong-jie;HUANG Xun;WU An-hua(Center for Healthcare-associated Infection Control,Xiangya Hospital,Central South University,Changsha 410008,China;Teaching and Research Section of Clinical Nursing,Xiangya Hospital,Central South University,Changsha 410008,China;Department of Healthcare-associated Infection Ma-nagement,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Healthcare-associated Infection Management,Fujian Medical University Union Hospital,Fuzhou 350001,China;Department of Infection Management,The First People’s Hospital of Yunnan Province,Kunming 650032,China;Department of Healthcare-associated Infection Management,The Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010017,China;Department of Healthcare-associated Infection Management,Guizhou Provincial People’s Hospital,Guiyang 550002,China;Office of Healthcare-associated Infection Management,Shandong Provincial Hospital,Shandong First Medical University,Jinan 250021,China;Department of Disease Control and Prevention,Army Medical Center,Chongqing 400042,China;Department of Infection Management,Henan Province Hospital of TCM,Zhengzhou 450002,China;Office of Healthcare-associated Infection Management,Hainan General Hospital,Haikou 570311,China;Department of Healthcare-associated Infection Management,Tongji Hospital,Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430030,China;Department of Infection Management,Tianjin Medical University General Hospital,Tianjin 300052,China)

机构地区：[1]中南大学湘雅医院医院感染控制中心,湖南长沙410008 [2]中南大学湘雅医院临床护理学教研室,湖南长沙410008 [3]郑州大学第一附属医院医院感染管理科,河南郑州450052 [4]福建医科大学附属协和医院医院感染管理科,福建福州350001 [5]云南省第一人民医院感染管理科,云南昆明650032 [6]内蒙古医科大学附属医院医院感染管理部,内蒙古呼和浩特010017 [7]贵州省人民医院医院感染管理科,贵州贵阳550002 [8]山东第一医科大学附属省立医院医院感染管理办公室,山东济南250021 [9]陆军特色医学中心疾病预防控制科,重庆400042 [10]河南省中医院(河南中医药大学第二附属医院河南中医药大学第二临床医学院)感染管理科,河南郑州450002 [11]海南省人民医院医院感染管理办公室,海南海口570311 [12]华中科技大学同济医学院附属同济医院医院感染管理科,湖北武汉430030 [13]天津医科大学总医院感染科,天津300052

出　　处：《中国感染控制杂志》2024年第1期1-8,共8页Chinese Journal of Infection Control

摘　　要：目的了解医疗机构住院患者丙型肝炎病毒(HCV)感染情况及变化趋势,为制定HCV感染防控策略提供参考依据。方法对2020年上报至全国医院感染监控网医院感染横断面调查资料中HCV感染监测结果进行汇总分析,HCV阳性为血清抗-HCV阳性或HCV RNA阳性,并与2003年调查结果进行比较。结果2020年1573所医院调查住院患者1071368例,其中738535例患者进行了HCV相关检测,4014例存在HCV感染,检测率为68.93%,HCV阳性率为0.54%。男性患者HCV阳性率为0.60%,女性患者为0.48%,两者比较差异有统计学意义(χ^(2)=47.18,P<0.001)。年龄段以50~<60岁组HCV阳性率最高(0.76%),其次为40~<50岁组,HCV阳性率为0.71%,各年龄段比较差异有统计学意义(χ^(2)=696.74,P<0.001)。2003年调查住院患者91113例,35145例进行HCV相关检测,检测率为38.57%,775例存在HCV感染,HCV阳性率为2.21%。2020年不同规模医院HCV阳性率为0.46%~0.63%,以医院床位数600~899张者最高,不同规模医院患者HCV阳性率比较,差异有统计学意义(χ^(2)=35.34,P<0.001)。2020年有12个省/直辖市/自治区HCV相关检测患者人数>10000例,HCV阳性率为0.19%~0.81%,以海南省最高;不同科室HCV阳性率为0.06%~0.82%,以儿科HCV阳性率最低,内科HCV阳性率最高。2003、2020年HCV阳性率均以感染病科最高,分别为7.95%、3.48%,2003年其次为整形科(7.72%)、消化科(3.77%)、肾病科(3.57%)、综合重症监护病房(ICU,3.10%),2020年其次为消化科(1.35%)、肾病科(1.18%)、内分泌科(0.91%)、综合ICU(0.79%)。结论与2003年相比,2020年HCV阳性率明显下降。HCV感染患者主要分布在感染病科,其次为消化科、肾病科及综合ICU,HCV感染阳性率存在性别、年龄、地域的差异。Objective To investigate the infection status and changing trend of hepatitis C virus(HCV)infection in hospitalized patients in medical institutions,and provide reference for formulating HCV infection prevention and control strategies.Methods HCV infection surveillance results from cross-sectional survey data reported to China Healthcare-associated Infection(HAI)Surveillance System in 2020 were summarized and analyzed,HCV positive was serum anti-HCV positive or HCV RNA positive,survey result was compared with the survey results from 2003.Results In 2020,1071368 inpatients in 1573 hospitals were surveyed,738535 of whom underwent HCV test,4014 patients were infected with HCV,with a detection rate of 68.93%and a HCV positive rate of 0.54%.The positive rate of HCV in male and female patients were 0.60%and 0.48%,respectively,with a statistically significant difference(χ^(2)=47.18,P<0.001).The HCV positive rate in the 50-<60 age group was the highest(0.76%),followed by the 40-<50 age group(0.71%).Difference among all age groups was statistically significant(χ^(2)=696.74,P<0.001).In 2003,91113 inpatients were surveyed,35145 of whom underwent HCV test,resulting in a detection rate of 38.57%;775 patients were infected with HCV,with a positive rate of 2.21%.In 2020,HCV positive rates in hospitals of different scales were 0.46%-0.63%,with the highest in hospital with bed numbers ranging 600-899.Patients’HCV positive rates in hospitals of different scales was statistically significant(χ^(2)=35.34,P<0.001).In 2020,12 provinces/municipalities had over 10000 patients underwent HCV-rela-ted test,and HCV positive rates ranged 0.19%-0.81%,with the highest rate from Hainan Province.HCV positive rates in different departments were 0.06%-0.82%,with the lowest positive rate in the department of pedia-trics and the highest in the department of internal medicine.In 2003 and 2020,HCV positive rates in the department of infectious diseases were the highest,being 7.95%and 3.48%,respectively.Followed by departments of orthopedics(7.72%

关 键 词：肝炎病毒 丙型 丙型肝炎病毒 流行病学调查 住院患者 发病率 

分 类 号：R181.32[医药卫生—流行病学]